Mixed connective tissue disease: Difference between revisions
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz mNo edit summary |
||
| Line 15: | Line 15: | ||
| isbn = 03230299396}}, p. 450</ref> In [[Medical Subject Headings]], it is termed "A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence." <ref>{{MeSH}}</ref> | | isbn = 03230299396}}, p. 450</ref> In [[Medical Subject Headings]], it is termed "A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence." <ref>{{MeSH}}</ref> | ||
From an immunologic standpoint,antibodies against | From an immunologic standpoint,antibodies against [[ U1 small nuclear ribonucleoprotein]]s (anti-U1 snRNP OR anti-U1 RNP) are characteristic.<ref>{{citation | ||
| journal = eMedicine Specialties > Rheumatology > Systemic Rheumatic Disease | | journal = eMedicine Specialties > Rheumatology > Systemic Rheumatic Disease | ||
| title =Mixed Connective-Tissue Disease: Overview | | title =Mixed Connective-Tissue Disease: Overview | ||
Revision as of 10:12, 31 July 2010
- See also: Scleroderma
First described in 1972, [1] often called distinct rheumatologic disease, mixed connective tissue disease (MCTD) is variously considered an overlap (i.e., overlap connective tissue disease) between systemic lupus erythematosus (SLE), scleroderma, and polymyositis; a specific subset of scleroderma with objective features of other diseases, such as SLE or polymyositis; or a distinct disease entity. [2] In Medical Subject Headings, it is termed "A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence." [3]
From an immunologic standpoint,antibodies against U1 small nuclear ribonucleoproteins (anti-U1 snRNP OR anti-U1 RNP) are characteristic.[4]
References
- ↑ Sharp GC; Irvin WS; Tan EM; Gould RG; Holman HR (1972), "Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).", Am J Med 52 (2)
- ↑ Fredrick M Wigley and Laura K Hummers (2004), Chapter 35: Clinical features of systemic sclerosis, Practical Rheumatology (Third ed.), Mosby, ISBN 03230299396, p. 450
- ↑ Anonymous (2024), Mixed connective tissue disease (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Robert W Hoffman and Eric L Greidinger, MD, Associate Professor, Department of (7 August 2008), "Mixed Connective-Tissue Disease: Overview", eMedicine Specialties > Rheumatology > Systemic Rheumatic Disease